Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · February 16, 2023

Efficacy and Safety of Treatment With Cannabidiol for Various Epilepsy Subtypes

Epilepsia Open


Additional Info

Epilepsia Open
Real-world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study
Epilepsia Open 2023 Jan 24;[EPub Ahead of Print], F Kühne, LL Becker, T Bast, A Bertsche, I Borggraefe, CM Boßelmann, J Fahrbach, C Hertzberg, NA Herz, M Hirsch, M Holtkamp, C Janello, GJ Kluger, G Kurlemann, H Lerche, KL Makridis, F von Podewils, M Pringsheim, S Schubert-Bast, J Schulz, A Schulze-Bonhage, D Steinbart, BJ Steinhoff, A Strzelczyk, S Syrbe, H De Vries, C Wagner, J Wagner, B Wilken, C Prager, KA Klotz, AM Kaindl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading